Expression of the p53 protein in a spectrum of astrocytic tumours

The Journal of Pathology

Volumn 168, Issue 4, 1992, Pages 383-386

  Ellison, David W ^a   Gatter, Kevin C ^b   Steart, Philip V ^a   Lane, David P ^c   Weller, Roy O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Astrocytoma; Glioblastoma; immunocytochemistry; p53

Indexed keywords

PROTEIN P53;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ASTROCYTOMA; BRAIN NEOPLASMS; GENE EXPRESSION; GENES, P53; GLIOBLASTOMA; HUMAN; NEOPLASM PROTEINS; PROTEIN P53;

EID: 0027051977     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711680408     Document Type: Article

References (14)

1. Editorial. Harris AL. Mutant p53—the commonest genetic abnormality in human cancer?
2. p53 expression in breast cancer
3. Rearrangement of the p53 gene in human osteogenic sarcomas
4. Increased expression of mutant forms of p53 oncogene in primary lung cancer
5. p53 expression in colorectal tumors
6. p53 mutations in human cancer
7. Mitotic recombination of chromosome 17 in astrocytomas
8. p53 mutation and loss of heterozygosity‐on chromosome 17 and 10 during human astrocytoma progression
9. Histological typing of tumours of the central nervous system
10. The p53 tumour suppressor gene
11. The p53 proto‐oncogene can act as a suppressor of transformation
12. Clonal expansion of p53 mutant cells is associated with brain tumour progression
13. Mutations in the p53 gene occur in diverse human tumour types
14. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin